国际肿瘤学杂志››2014,Vol. 41››Issue (11): 805-807.doi:10.3760/cma.j.issn.1673422X.2014.11.002
王焕昇, 李庞, 李胜
出版日期:
2014-12-03发布日期:
2015-01-20通讯作者:
李胜,Email: drlisheng@sohu.com基金资助:
国家重点基础研究发展计划(2011CB504302)
WANG Huan-Sheng, LI Pang, LI Sheng
Online:
2014-12-03Published:
2015-01-20Contact:
Li Sheng, Email: drlisheng@sohu.com摘要:循环肿瘤细胞(CTC)具有的特异性(上皮间质转化、与骨髓来源细胞的融合、抗失巢凋亡)决定了将其作为原代目标进行培养的必要性,所培养出的细胞株将为进一步研究恶性肿瘤的转移机制提供良好的物质基础,为患者的靶向治疗提供个体化的新方向。
王焕昇, 李庞, 李胜. 循环肿瘤细胞株的建立[J]. 国际肿瘤学杂志, 2014, 41(11): 805-807.
WANG Huan-Sheng, LI Pang, LI Sheng. Establishment of circulating tumor cell linesWang[J]. Journal of International Oncology, 2014, 41(11): 805-807.
[1] Ilina O, Friedl P. Mechanisms of collective cell migration at a glance[J]. Cell Sci, 2009, 122(Pt 18):32033208. [2] Thompson EW, Haviv I. The social aspects of EMTMET plasticity[J]. Nat Med, 2011, 17(9):10481049. [3] Hao J, Zhang Y, Deng M, et al. MicroRNA control of epithelialmesenchymal transition in cancer stem cells[J]. Int J Cancer, 2014, 135(5):10191027. [4] Cowin P, Wysolmerski J. Molecular mechanisms guiding embryonic mammary gland development[J]. Cold Spring Harb Perspect Biol, 2010, 2(6):a003251. [5] Hou JM, Krebs M, Ward T, et al. Circulating tumor cells as a window on metastasis biology in lung cancer[J]. Am Pathol, 2011, 178(3):989996. [6] Kallergi G, Papadaki MA, Politaki E, et al. Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients[J]. Breast Cancer Res, 2011, 13(3):R59. [7] Kallergi G, Konstantinidis G, Markomanolaki H, et al. Apoptotic circulating tumor cells in early and metastatic breast cancer patients[J]. Mol Cancer Ther, 2013, 12(9):18861895. [8] Bonnomet A, Brysse A, Tachsidis A, et al. Epithelialtomesenchymal transitions and circulating tumor cells[J]. Mammary Gland Biol Neoplasia, 2010, 15(2):261273. [9] Dondossola E, Rangel R, GuzmanRojas L, et al. CD13positive bone marrowderived myeloid cells promote angiogenesis, tumor growth, and metastasis[J]. Proc Natl Acad Sci USA, 2013, 110(51):2071720722. [10] Shaked Y, McAllister S, Fainaru O, et al. Tumor dormancy and the angiogenic switch: possible implications of bone marrowderived cells[J]. Curr Pharm Des, 2014, 20(30):49204933. [11] Fan Q, Gu D, Liu H, et al. Defective TGFbeta signaling in bone marrowderived cells prevents hedgehoginduced skin tumors[J]. Cancer Res, 2014, 74(2):471483. [12] Peinado H, Aleckovic M, Lavotshkin S, et al.Melanoma exosomes educate bone marrow progenitor cells toward a prometastatic phenotype through MET[J]. Nat Med, 2012; 18(6):883891. [13] Kumar S, Park SH, Cieply B, et al. A pathway for the control of anoikis sensitivity by Ecadherin and epithelialtomesenchymal transition[J]. Mol Cell Biol, 2011, 31(19):40364051. [14] Park SH, Riley P 4th, Frisch SM. Regulation of anoikis by deleted in breast cancer1 (DBC1) through NFkappaB[J]. Apoptosis, 2013, 18(8):949962. [15] Yao X, Choudhury AD, Yamanaka YJ, et al. Functional analysis of single cells identifies a rare subset of circulating tumor cells with malignant traits[J]. Integr Biol (Camb), 2014, 6(4):388398. [16] 周开华, 陈晓丹, 宋鑫. 恶性胸水培养肿瘤细胞失败原因分析[J]. 昆明医学院学报, 2011, 32(5):4749,57. [17] Desitter I, Guerrouahen BS, BenaliFuret N, et al. A new device for rapid isolation by size and characterization of rare circulating tumor cells[J]. Anticancer Res, 2011, 31(2):427441. [18] Lin HK, Zheng S, Williams AJ, et al. Portable filterbased microdevice for detection and characterization of circulating tumor cells[J]. Clin Cancer Res, 2010, 16(20):50115018. [19] Hou JM, Krebs MG, Lancashire L, et al. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with smallcell lung cancer[J]. J Clin Oncol, 2012, 30(5):525532. [20] Stott SL, Hsu CH, Tsukrov DI, et al. Isolation of circulating tumor cells using a microvortexgenerating herringbonechip[J]. Proc Natl Acad Sci USA, 2010, 107(43):1839218397. [21] Zheng S, Lin HK, Lu B, et al. 3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood[J]. Biomed Microdevices, 2011, 13(1):203213. [22] Krebs MG, Hou JM, Sloane R, et al.Analysis of circulating tumor cells in patients with nonsmall cell lung cancer using epithelial markerdependent and independent approaches[J]. Thorac Oncol, 2012, 7(2):306315. [23] Ma YC, Wang L, Yu FL, et al. Recent advances and prospects in the isolation by size of epithelial tumor cells (ISET) methodology[J]. Technol Cancer Res Treat, 2013, 12(4):295309. [24] Tinhofer I, Saki M, Niehr F, et al. Cancer stem cell characteristics of circulating tumor cells[J]. Int J Radiat Biol, 2014, 90(8):622627. |
[1] | 陈罗军,李娜,田景媛,宋启斌,于金明.循环肿瘤细胞在临床应用中的研究进展[J]. 国际肿瘤学杂志, 2018, 45(8): 552-555. |
[2] | 邹江, 郭晓兰.液体活检在肿瘤诊治中的研究进展[J]. 国际肿瘤学杂志, 2018, 45(2): 107-111. |
[3] | 于华杰,韩露,欧洋,李胜,高德海.荧光在循环肿瘤细胞鉴定中的应用[J]. 国际肿瘤学杂志, 2018, 45(1): 35-. |
[4] | 李树玲,刘晶,魏文青.循环肿瘤细胞检测技术[J]. 国际肿瘤学杂志, 2016, 43(5): 368-371. |
[5] | 冯飞,秦颂兵.三维细胞模型在肿瘤实验中的应用[J]. 国际肿瘤学杂志, 2015, 42(7): 532-534. |
[6] | 李浩;李胜;张百江.循环肿瘤细胞检测在非小细胞肺癌中的应用[J]. 国际肿瘤学杂志, 2015, 42(4): 298-300. |
[7] | 倪婷, 王玉东.肿瘤细胞弥散机制及循环肿瘤细胞的检测和临床应用[J]. 国际肿瘤学杂志, 2015, 42(11): 841-844. |
[8] | 高洋, 袁周.纳米技术在循环肿瘤细胞中的研究进展[J]. 国际肿瘤学杂志, 2015, 42(1): 46-48. |
[9] | 邢震宇, 张会弟, 高磊, 常文龙, 田少辉, 张辉.斑蝥酸钠对体外培养肺癌患者淋巴细胞免疫应答的影响[J]. 国际肿瘤学杂志, 2014, 41(11): 862-865. |
[10] | 巩佃霞, 李贵新, 路中,等.循环肿瘤细胞检测技术及其在非小细胞肺癌中临床应用[J]. 国际肿瘤学杂志, 2013, 40(10): 769-771. |
[11] | 夏凡, 赵腾, 王艳.肺癌中循环肿瘤细胞的检测[J]. 国际肿瘤学杂志, 2012, 39(7): 523-525. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||